Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: The fukuoka stroke registry

Stroke

Volumn 42, Issue 10, 2011, Pages 2788-2794

  Kamouchi, Masahiro ^a   Matsuki, Takayuki ^a   Hata, Jun ^a,b   Kuwashiro, Takahiro ^a   Ago, Tetsuro ^a   Sambongi, Yoshiki ^a   Fukushima, Yoshihisa ^a   Sugimori, Hiroshi ^a,b   Kitazono, Takanari ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

brain infarction; diabetes; hyperglycemia; prognosis

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEATH; DEPENDENT PERSONALITY DISORDER; DETERIORATION; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; GENDER; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; PATIENT CODING; PRESTROKE GLYCEMIC CONTROL; PRIORITY JOURNAL; RANKIN SCALE; STROKE PATIENT;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BRAIN ISCHEMIA; DIABETES MELLITUS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME;

EID: 80053312968     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.617415     Document Type: Article

References (30)

1. Fujishima M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama study. Diabetes. 1996;45 Suppl 3:S14-S16.
2. Doi Y, Ninomiya T, Hata J, Fukuhara M, Yonemoto K, Iwase M, et al. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: The Hisayama study. Stroke. 2010;41:203-209.
3. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke. Prospective study of the middle-aged Finnish population. Stroke. 1996;27:210-215. (Pubitemid 26044488)
4. Megherbi SE, Milan C, Minier D, Couvreur G, Osseby GV, Tilling K, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: Data from the European Biomed Stroke Project. Stroke. 2003;34:688-694. (Pubitemid 36307394)
5. Mankovsky BN, Ziegler D. Stroke in patients with diabetes mellitus. Diabetes Metab Res Rev. 2004;20:268-287. (Pubitemid 39077478)
6. Adams HP Jr, Olinger CP, Marler JR, Biller J, Brott TG, Barsan WG, et al. Comparison of admission serum glucose concentration with neurologic outcome in acute cerebral infarction. A study in patients given naloxone. Stroke. 1988;19:455-458.
7. Matchar DB, Divine GW, Heyman A, Feussner JR. The influence of hyperglycemia on outcome of cerebral infarction. Ann Intern Med. 1992; 117:449-456.
8. Toni D, Sacchetti ML, Argentino C, Gentile M, Cavalletti C, Frontoni M, et al. Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients? J Neurol. 1992;239:382-386.
9. Murros K, Fogelholm R, Kettunen S, Vuorela AL, Valve J. Blood glucose, glycosylated haemoglobin, and outcome of ischemic brain infarction. J Neurol Sci. 1992;111:59-64.
10. Special report from the national institute of neurological disorders and stroke. Classification of Cerebrovascular Diseases III. Stroke. 1990;21: 637-676.
11. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41. (Pubitemid 23014379)
12. Cardiogenic brain embolism. Cerebral embolism task force. Arch Neurol. 1986;43:71-84.
13. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int. 2010;1:2-20.
14. Japan Diabetes Society. Treatment objectives and control indicators. In: Japan Diabetes Society ed. Treatment guide for diabetes 2007. Tokyo: Bunkodo;2007:1-84.
15. Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke. 2008;39:2749-2755.
16. Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol. 2005;62:393-397. (Pubitemid 40349474)
17. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314:1303-1306. (Pubitemid 27183316)
18. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology. 2002;59:669-674.
19. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, et al. Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20-28. (Pubitemid 34693739)
20. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59:67-71. (Pubitemid 34742796)
21. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34: 2208-2214. (Pubitemid 37099838)
22. Fuentes B, Castillo J, San Jose B, Leira R, Serena J, Vivancos J, et al. The prognostic value of capillary glucose levels in acute stroke: The GLycemia in Acute Stroke (GLIAS) study. Stroke. 2009;40:562-568.
23. Ahmed N, Davalos A, Eriksson N, Ford GA, Glahn J, Hennerici M, et al. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: Results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITSISTR). Arch Neurol. 2010;67:1123-1130.
24. Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care. 2009;32:617-622.
25. Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: A mechanistic justification for a trial of insulin infusion therapy. Stroke. 2006;37:267-273. (Pubitemid 43732090)
26. Toyoda K, Fujimoto S, Kamouchi M, Iida M, Okada Y. Acute blood pressure levels and neurological deterioration in different subtypes of ischemic stroke. Stroke. 2009;40:2585-2588.
27. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559. (Pubitemid 351831356)
28. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129-139.
29. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-2572. (Pubitemid 351831357)
30. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009; 32:193-203.